SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001827506-24-000076
Filing Date
2024-08-22
Accepted
2024-08-22 16:22:14
Documents
1
Period of Report
2024-08-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1724358128.html 4  
1 FORM 4 wk-form4_1724358128.xml 4 4267
  Complete submission text file 0001827506-24-000076.txt   5850
Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Issuer) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 92 MORNINGSIDE AVE. APT 7E NEW YORK NM 10027
Business Address
Kulkarni Sandeep Chidambar (Reporting) CIK: 0001945691 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40384 | Film No.: 241232257